Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 1
2012 1
2013 1
2014 1
2015 2
2017 1
2018 2
2020 1
2021 1
2022 2
2023 1
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
Choueiri TK, Powles T, Burotto M, Escudier B, Bourlon MT, Zurawski B, Oyervides Juárez VM, Hsieh JJ, Basso U, Shah AY, Suárez C, Hamzaj A, Goh JC, Barrios C, Richardet M, Porta C, Kowalyszyn R, Feregrino JP, Żołnierek J, Pook D, Kessler ER, Tomita Y, Mizuno R, Bedke J, Zhang J, Maurer MA, Simsek B, Ejzykowicz F, Schwab GM, Apolo AB, Motzer RJ; CheckMate 9ER Investigators. Choueiri TK, et al. N Engl J Med. 2021 Mar 4;384(9):829-841. doi: 10.1056/NEJMoa2026982. N Engl J Med. 2021. PMID: 33657295 Free PMC article. Clinical Trial.
Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651.
Haddad RI, Harrington K, Tahara M, Ferris RL, Gillison M, Fayette J, Daste A, Koralewski P, Zurawski B, Taberna M, Saba NF, Mak M, Kawecki A, Girotto G, Alvarez Avitia MA, Even C, Toledo JGR, Guminski A, Müller-Richter U, Kiyota N, Roberts M, Khan TA, Miller-Moslin K, Wei L, Argiris A. Haddad RI, et al. Among authors: alvarez avitia ma. J Clin Oncol. 2023 Apr 20;41(12):2166-2180. doi: 10.1200/JCO.22.00332. Epub 2022 Dec 6. J Clin Oncol. 2023. PMID: 36473143 Free PMC article. Clinical Trial.
Sinonasal Teratocarcinosarcoma: Letter to the Editor of multimodal approach.
Luna-Ortíz K, Guillén-Hernández GA, Navarro-Fernández JO, Cano-Valdez AM, Alvárez-Avitia MA, Luna-Peteuil Z, Yescas-Castellanos SS, García-Ortega DY. Luna-Ortíz K, et al. Among authors: alvarez avitia ma. Oral Oncol. 2025 Aug;167:107459. doi: 10.1016/j.oraloncology.2025.107459. Epub 2025 Jul 2. Oral Oncol. 2025. PMID: 40609407 No abstract available.
Multitarget Molecular Imaging in Metastatic Castration Resistant Adenocarcinoma Prostate Cancer with Therapy Induced Neuroendocrine Differentiation.
Vargas Ahumada J, González Rueda SD, Sinisterra Solís FA, Pitalúa Cortés Q, Torres Agredo LP, Miguel JR, Scavuzzo A, Soldevilla-Gallardo I, Álvarez Avitia MA, Sobrevilla N, García Pérez FO. Vargas Ahumada J, et al. Among authors: alvarez avitia ma. Diagnostics (Basel). 2022 Jun 3;12(6):1387. doi: 10.3390/diagnostics12061387. Diagnostics (Basel). 2022. PMID: 35741197 Free PMC article.
[Third National Ovarian Consensus. 2011. Grupo de Investigación en Cáncer de Ovario y Tumores Ginecológicos de México "GICOM"].
Gallardo-Rincón D, Cantú-de-León D, Alanís-López P, Alvarez-Avitia MA, Bañuelos-Flores J, Herbert-Núñez GS, Oñate-Ocaña LF, Pérez-Montiel MD, Rodríguez-Trejo A, Ruvalcaba-Limón E, Serrano-Olvera A, Ortega-Rojo A, Cortés-Esteban P, Erazo-Valle A, Gerson-Cwilich R, De-la-Garza-Salazar J, Green-Renner D, León-Rodríguez E, Morales-Vásquez F, Poveda-Velasco A, Aguilar-Ponce JL, Alva-López LF, Alvarado-Aguilar S, Alvarado-Cabrero I, Aquino-Mendoza CA, Aranda-Flores CE, Bandera-Delgado A, Barragán-Curiel E, Barrón-Rodríguez P, Brom-Valladares R, Cabrera-Galeana PA, Calderillo-Ruiz G, Camacho-Gutiérrez S, Capdeville-García D, Cárdenas-Sánchez J, Carlón-Zárate E, Carrillo-Garibaldi O, Castorena-Roji G, Cervantes-Sánchez G, Coronel-Martínez JA, Chanona-Vilchis JG, Díaz-Hernández V, Escudero-de-los Ríos P, Garibay-Cerdenares O, Gómez-García E, Herrera-Montalvo LA, Hinojosa-García LM, Isla-Ortiz D, Jiménez-López J, Lavín-Lozano AJ, Limón-Rodriguez JA, López-Basave HN, López-García SC, Maffuz-Aziz A, Martínez-Cedillo J, Martínez-López DM, Medina-Castro JM, Melo-Martínez C, Méndez-Herrera C, Montalvo-Esquivel G, Morales-Palomares MA, Morán-Mendoza A, Morgan-Villela G, Mota-García A, Muño… See abstract for full author list ➔ Gallardo-Rincón D, et al. Among authors: alvarez avitia ma. Rev Invest Clin. 2011 Nov-Dec;63(6):665-702. Rev Invest Clin. 2011. PMID: 23650680 Spanish.
Frequency of BRAF V600E Mutation in the Mexican Population of Patients With Metastatic Melanoma.
Ruiz-Garcia E, Matus-Santos JA, Guadarrama-Orozco JA, Alvarez-Avitia MA, Aguilar-Ponce JL, Fernandez-Figueroa E, Maldonado-Mendoza J, Lopez-Camarillo C, Marchat LA, Lino-Silva S, Cuellar-Hubbe M, de la Garza-Salazar J, Meneses-García A, Astudillo-de la Vega H, Martinez-Said H. Ruiz-Garcia E, et al. Among authors: alvarez avitia ma. J Glob Oncol. 2018 Sep;4:1-5. doi: 10.1200/JGO.2016.008912. Epub 2017 Jun 12. J Glob Oncol. 2018. PMID: 30241212 Free PMC article.
15 results